Barbara Campling, MD

Contact Dr. Campling

925 Chestnut Street
Suite 320A
Philadelphia, PA 19107

(215) 955-8874

Medical School
University of Western Ontario, Canada

Residency
University of Toronto, Canada

Fellowship
University of Toronto, Canada

Board Certification
Internal Medicine

Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital

Hospital Appointment
Active Medical Staff

University Appointment
Professor of Medical Oncology

Research and Clinical Interests
Medical Oncology, Head and Neck Cancers, Lung Cancer

Publications

Most recent Peer-reviewed Publications

1. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy
2. Spontaneous smoking cessation before lung cancer diagnosis
3. The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
4. The problem of platinum resistance
5. A population-based study of lung carcinoma in Pennsylvania: Comparison of Veterans Administration and Civilian Populations
6. Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer
7. Topotecan in small cell lung cancer: First or second line?
8. Clinical implications of p53 mutations in lung cancer.
9. Clinical implication of p53 mutation in lung cancer
10. Therapy and disease concepts: The history (and future?) of antimony in cancer
11. Constitutive activation of Met kinase in non-small-cell lung carcinomas correlates with anchorage-independent cell survival
12. Clinical and molecular features of small cell lung cancer
13. The role of single-agent docetaxel as second-line treatment for advanced non-small-cell lung cancer
14. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: Correlation of protein levels with drug response and messenger RNA levels
15. Enhanced anti-cancer activities of some derivatives of titanocene dichloride
16. Simultaneous quantitation of topoisomerase II α and β isoform mRNAs in lung tumor cells and normal and malignant lung tissue
17. A truncated cytoplasmic topoisomerase IIα in a drug-resistant lung cancer cell line is encoded by a TOP2A allele with a partial deletion of exon 34
18. Altered fractionation of radical radiaton therapy in the management of unresectable non-small-cell lung cancer
19. The role of thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small-cell lung cancer
20. Gap junctional communication in cultured human lung carcinoma cells

View All Publications